Join the club for FREE to access the whole archive and other member benefits.

Radical new cancer treatment to be trialled next year


Key points from article :

Uses cancer-killing cells from people with the strongest immune systems.

Neutrophil cells form part of the body’s first line of defence.

Multiplied millions of times and injected into cancer patients.

Initially focusing on pancreatic cancer.

Hope to see patients experiencing complete remission

Mentioned in this article:

Tap on icon for description, click on resource name for more details.

Company Representative

Founder and Chief Executive Officer of LIfT BioSciences.


Professor of Molecular Medicine at King's College London.


Public research university


Biotechnology company that develops a portfolio of potentially life-saving immuno-oncology cell therapies